ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease. ADVENTRX seeks to improve the performance and commercial potential of existing treatments by addressing limitations associated with these treatment regimens.

Our goal is to be a leading biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease.

The Company's near-term strategy is to obtain marketing approval of its existing product candidates and either partner or establish an infrastructure to support marketing, distributing and selling our products in the U.S. and abroad, should they be approved. Longer term, we intend to acquire additional product candidates that fit its areas of expertise in cancer and infectious disease.